Irrelevance of CHEK2 variants to diagnosis of breast/ovarian cancer predisposition in Polish cohort-Reference-Cited by-同舟云学术

Irrelevance of CHEK2 variants to diagnosis of breast/ovarian cancer predisposition in Polish cohort

Published:2010-12-01 Issue:2 Volume:52 Page:185-191
ISSN:1234-1983
Container-title:Journal of Applied Genetics
language:en
Short-container-title:J Appl Genetics

Author:

Myszka Aleksander,Karpinski Pawel,Slezak Ryszard,Czemarmazowicz Halina,Stembalska Agnieszka,Gil Justyna,Laczmanska Izabela,Bednarczyk Damian,Szmida Elzbieta,Sasiadek Maria Malgorzata

Publisher

Springer Science and Business Media LLC

Subject

Genetics,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s13353-010-0013-1.pdf

Reference42 articles.

1. Allinen M, Huusko P, Mäntyniemi S, Launonen V, Winqvist R (2001) Mutation analysis of the CHK2 gene in families with hereditary breast cancer. Br J Cancer 85:209–212

2. Bell DW, Varley JM, Szydlo TE, Kang DH, Wahrer DC, Shannon KE et al (1999) Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome. Science 286:2528–2531

3. Bell DW, Kim SH, Godwin AK, Schiripo TA, Harris PL, Haserlat SM et al (2007) Genetic and functional analysis of CHEK2 (CHK2) variants in multiethnic cohorts. Int J Cancer 121:2661–2667

4. Berliner JL, Fay AM (2007) Risk assessment and genetic counseling for hereditary breast and ovarian cancer: recommendations of the National Society of Genetic Counselors. J Genet Couns 16:241–260

5. Bogdanova N, Enssen-Dubrowinskaja N, Feshchenko S, Lazjuk GI, Rogov YI, Dammann O et al (2005) Association of two mutations in the CHEK2 gene with breast cancer. Int J Cancer 116:263–266

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Spectrum and frequency of CHEK2 variants in breast cancer affected and general population in the Baltic states region, initial results and literature review;European Journal of Medical Genetics;2022-05

2. Association of recurrent mutations in BRCA1, BRCA2, RAD51C, PALB2, and CHEK2 with the risk of borderline ovarian tumor;Hereditary Cancer in Clinical Practice;2022-03-21

3. Recurrent Mutations in BRCA1, BRCA2, RAD51C, PALB2 and CHEK2 in Polish Patients with Ovarian Cancer;Cancers;2021-02-18

4. Ethnic Features of Genetic Susceptibility to Breast Cancer;Russian Journal of Genetics;2018-02

5. The CHEK2 del5395 is a founder mutation without direct effects for cancer risk in the latvian population;Balkan Journal of Medical Genetics;2015-12-01